13F-HR filed by Boxer Capital, LLC
Boxer Capital, LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 74 holding rows worth $1,945,613,000.
- Accession
- 0000950123-22-006483
- Filer
- CIK 1465837
- Filed
- 2022-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 74 entries on the cover page, a total value of $1,945,613,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,945,613,000 with VALUE read as thousands by filing date, 13F file number 028-17339. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 2,000,000 | $164,440,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 2,075,905 | $117,164,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 3,192,058 | $102,720,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 500,000 | $94,300,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 3,484,264 | $88,884,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 2,669,132 | $79,887,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 2,100,000 | $77,301,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 3,498,636 | $72,842,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 6,448,359 | $68,997,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,303,700 | $66,241,000 | thousands by filing date | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 1,714,000 | $64,721,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 700,000 | $62,916,000 | thousands by filing date | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 6,871,642 | $52,087,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 1,900,000 | $50,236,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 1,432,200 | $45,200,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 1,239,000 | $40,590,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 1,094,000 | $36,211,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 507,374 | $32,411,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,935,133 | $32,220,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 1,300,000 | $32,162,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 1,263,930 | $30,574,000 | thousands by filing date | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 2,200,000 | $28,270,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 2,202,812 | $24,649,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,466,051 | $23,252,000 | thousands by filing date | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 4,341,009 | $22,834,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 2,325,000 | $22,018,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 3,200,000 | $22,016,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 2,462,358 | $21,373,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 1,847,559 | $20,804,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 1,121,327 | $20,711,000 | thousands by filing date | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 2,500,000 | $19,925,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 500,000 | $19,385,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 1,013,399 | $18,535,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 600,000 | $18,342,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 1,224,892 | $17,161,000 | thousands by filing date | |
| NUVALENT INC COM | 670703107 | Stock | 1,210,192 | $16,810,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 200,000 | $14,524,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 2,238,861 | $14,373,000 | thousands by filing date | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 1,189,943 | $11,804,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 831,495 | $11,799,000 | thousands by filing date | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,251,137 | $11,273,000 | thousands by filing date | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,074,082 | $11,246,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 300,000 | $10,971,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 400,000 | $10,740,000 | thousands by filing date | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 892,057 | $10,285,000 | thousands by filing date | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 459,836 | $7,845,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 500,000 | $7,625,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 2,202,333 | $6,981,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 5,336,031 | $6,403,000 | thousands by filing date | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 1,175,000 | $5,957,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,054,000 | $5,628,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 2,014,858 | $5,581,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 4,207,086 | $5,553,000 | thousands by filing date | |
| CODIAK BIOSCIENCES INC | 192010106 | COM | 850,065 | $5,330,000 | thousands by filing date | |
| BIOMEA FUSION INC | 09077A106 | CMN | 1,188,405 | $5,300,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 500,000 | $4,935,000 | thousands by filing date | |
| PANACEA ACQUISITION CORP II | G6882C106 | COM | 500,000 | $4,875,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 724,500 | $4,485,000 | thousands by filing date | |
| EQRX INC | 26886C107 | COM | 1,000,000 | $4,130,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 3,284,072 | $4,039,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 400,000 | $3,964,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 686,347 | $3,452,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 2,134,598 | $3,394,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 1,526,048 | $3,281,000 | thousands by filing date | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 872,780 | $2,199,000 | thousands by filing date | |
| OMEGA ALPHA SPAC | G6749V107 | CL A | 200,000 | $1,964,000 | thousands by filing date | |
| GEMINI THERAPEUTICS INC | 36870G105 | CMN | 1,300,000 | $1,807,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 2,913,091 | $1,755,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427401 | COMMON STOCK | 1,134,453 | $1,418,000 | thousands by filing date | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 540,000 | $1,096,000 | thousands by filing date | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 209,227 | $1,069,000 | thousands by filing date | |
| NUVATION BIO INC | 67080N119 | WARR | 266,666 | $203,000 | thousands by filing date | |
| BELLICUM PHARMACEUTICALS INC COM NEW | 079481404 | Stock | 56,950 | $123,000 | thousands by filing date | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 66,666 | $17,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-22-006483 | this filing | 2022-05-16 | acceptance time not in the bulk data set |